MICHELLE MIKE-NICHOLS: Open Payments
NPI 1508873415 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,810 in 86 payments from 29 companies in 2025. Trend: 2023 $2,181 · 2024 $1,693 · 2025 $1,810
Food & beverage: $1,810
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 7 | $354 |
| Novo Nordisk Inc | 13 | $191 |
| Novartis Pharmaceuticals Corporation | 7 | $140 |
| Corcept Therapeutics | 5 | $98 |
| Amgen Inc. | 5 | $86 |
| Lilly USA, LLC | 4 | $73 |
| Medtronic, Inc. | 4 | $69 |
| ABBVIE INC. | 3 | $69 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $61 |
| Xeris Pharmaceuticals, Inc. | 3 | $59 |
Products named: Omnipod, LEQVIO, Ozempic, Korlym, ISTURISA, Kerendia, FREESTYLE LIBRE 3, CRENESSITY.
Industry payments across KY — which companies pay providers there.
